Genetic and Functional Analyses of Mutations Suggest a Multiple Hit Model of Autism Spectrum Disorders
Autism spectrum disorders (ASD) are a heterogeneous group of neurodevelopmental disorders with a complex inheritance pattern. While many rare variants in synaptic proteins have been identified in patients with ASD, little is known about their effects at the synapse and their interactions with other genetic variations. Here, following the discovery of two de novo SHANK2 deletions by the Autism Genome Project, we identified a novel 421 kb de novo SHANK2 deletion in a patient with autism. We then sequenced SHANK2 in 455 patients with ASD and 431 controls and integrated these results with those reported by Berkel et al. 2010 (n = 396 patients and n = 659 controls). We observed a significant enrichment of variants affecting conserved amino acids in 29 of 851 (3.4%) patients and in 16 of 1,090 (1.5%) controls (P = 0.004, OR = 2.37, 95% CI = 1.23–4.70). In neuronal cell cultures, the variants identified in patients were associated with a reduced synaptic density at dendrites compared to the variants only detected in controls (P = 0.0013). Interestingly, the three patients with de novo SHANK2 deletions also carried inherited CNVs at 15q11–q13 previously associated with neuropsychiatric disorders. In two cases, the nicotinic receptor CHRNA7 was duplicated and in one case the synaptic translation repressor CYFIP1 was deleted. These results strengthen the role of synaptic gene dysfunction in ASD but also highlight the presence of putative modifier genes, which is in keeping with the “multiple hit model” for ASD. A better knowledge of these genetic interactions will be necessary to understand the complex inheritance pattern of ASD.
Vyšlo v časopise:
Genetic and Functional Analyses of Mutations Suggest a Multiple Hit Model of Autism Spectrum Disorders. PLoS Genet 8(2): e32767. doi:10.1371/journal.pgen.1002521
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pgen.1002521
Souhrn
Autism spectrum disorders (ASD) are a heterogeneous group of neurodevelopmental disorders with a complex inheritance pattern. While many rare variants in synaptic proteins have been identified in patients with ASD, little is known about their effects at the synapse and their interactions with other genetic variations. Here, following the discovery of two de novo SHANK2 deletions by the Autism Genome Project, we identified a novel 421 kb de novo SHANK2 deletion in a patient with autism. We then sequenced SHANK2 in 455 patients with ASD and 431 controls and integrated these results with those reported by Berkel et al. 2010 (n = 396 patients and n = 659 controls). We observed a significant enrichment of variants affecting conserved amino acids in 29 of 851 (3.4%) patients and in 16 of 1,090 (1.5%) controls (P = 0.004, OR = 2.37, 95% CI = 1.23–4.70). In neuronal cell cultures, the variants identified in patients were associated with a reduced synaptic density at dendrites compared to the variants only detected in controls (P = 0.0013). Interestingly, the three patients with de novo SHANK2 deletions also carried inherited CNVs at 15q11–q13 previously associated with neuropsychiatric disorders. In two cases, the nicotinic receptor CHRNA7 was duplicated and in one case the synaptic translation repressor CYFIP1 was deleted. These results strengthen the role of synaptic gene dysfunction in ASD but also highlight the presence of putative modifier genes, which is in keeping with the “multiple hit model” for ASD. A better knowledge of these genetic interactions will be necessary to understand the complex inheritance pattern of ASD.
Zdroje
1. American Psychiatric Association 1994 Diagnostic and Statistical Manual of Mental Disorders, 4th Ed American Psychiatric Press, Washington D.C
2. FernellEGillbergC 2010 Autism spectrum disorder diagnoses in Stockholm preschoolers. Res Dev Disabil 31 680 685
3. FreitagCM 2007 The genetics of autistic disorders and its clinical relevance: a review of the literature. Mol Psychiatry 12 2 22
4. HallmayerJClevelandSTorresAPhillipsJCohenB 2011 Genetic Heritability and Shared Environmental Factors Among Twin Pairs With Autism. Arch Gen Psychiatry
5. BourgeronT 2009 A synaptic trek to autism. Curr Opin Neurobiol 19 231 234
6. ToroRKonyukhMDelormeRLeblondCChasteP 2010 Key role for gene dosage and synaptic homeostasis in autism spectrum disorders. Trends Genet in press
7. DurandCMBetancurCBoeckersTMBockmannJChasteP 2007 Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders. Nat Genet 39 25 27
8. JamainSQuachHBetancurCRastamMColineauxC 2003 Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. Nat Genet 34 27 29
9. PintoDPagnamentaATKleiLAnneyRMericoD 2010 Functional impact of global rare copy number variation in autism spectrum disorders. Nature 466 368 372
10. SzatmariPPatersonADZwaigenbaumLRobertsWBrianJ 2007 Mapping autism risk loci using genetic linkage and chromosomal rearrangements. Nat Genet 39 319 328
11. ReddyKS 2005 Cytogenetic abnormalities and fragile-X syndrome in Autism Spectrum Disorder. BMC Med Genet 6 3
12. O'RoakBJDeriziotisPLeeCVivesLSchwartzJJ 2011 Exome sequencing in sporadic autism spectrum disorders identifies severe de novo mutations. Nat Genet 43 585 589
13. SandersSJErcan-SencicekAGHusVLuoRMurthaMT 2011 Multiple Recurrent De Novo CNVs, Including Duplications of the 7q11.23 Williams Syndrome Region, Are Strongly Associated with Autism. Neuron 70 863 885
14. LevyDRonemusMYamromBLeeYHLeottaA 2011 Rare de novo and transmitted copy-number variation in autistic spectrum disorders. Neuron 70 886 897
15. PootMBeyerVSchwaabIDamatovaNVan't SlotR 2010 Disruption of CNTNAP2 and additional structural genome changes in a boy with speech delay and autism spectrum disorder. Neurogenetics 11 81 89
16. SchaafCPSaboASakaiYCrosbyJMuznyD 2011 Oligogenic heterozygosity in individuals with high-functioning autism spectrum disorders. Hum Mol Genet 20 3366 3375
17. GirirajanSRosenfeldJACooperGMAntonacciFSiswaraP 2010 A recurrent 16p12.1 microdeletion supports a two-hit model for severe developmental delay. Nat Genet 42 203 209
18. BetancurC 2011 Etiological heterogeneity in autism spectrum disorders: More than 100 genetic and genomic disorders and still counting. Brain Res 1380 42 77
19. GilmanSRIossifovILevyDRonemusMWiglerM 2011 Rare de novo variants associated with autism implicate a large functional network of genes involved in formation and function of synapses. Neuron 70 898 907
20. CooperGMCoeBPGirirajanSRosenfeldJAVuTH 2011 A copy number variation morbidity map of developmental delay. Nat Genet 43 838 846
21. SudhofTC 2008 Neuroligins and neurexins link synaptic function to cognitive disease. Nature 455 903 911
22. YuLMGodaY 2009 Dendritic signalling and homeostatic adaptation. Curr Opin Neurobiol 19 327 335
23. MoessnerRMarshallCRSutcliffeJSSkaugJPintoD 2007 Contribution of SHANK3 mutations to autism spectrum disorder. Am J Hum Genet 81 1289 1297
24. GauthierJChampagneNLafreniereRGXiongLSpiegelmanD 2010 De novo mutations in the gene encoding the synaptic scaffolding protein SHANK3 in patients ascertained for schizophrenia. Proc Natl Acad Sci U S A 107 7863 7868
25. HamdanFFGauthierJArakiYLinDTYoshizawaY 2011 Excess of de novo deleterious mutations in genes associated with glutamatergic systems in nonsyndromic intellectual disability. Am J Hum Genet 88 306 316
26. BerkelSMarshallCRWeissBHoweJRoethR 2010 Mutations in the SHANK2 synaptic scaffolding gene in autism spectrum disorder and mental retardation. Nat Genet 42 489 491
27. PersicoAMBourgeronT 2006 Searching for ways out of the autism maze: genetic, epigenetic and environmental clues. Trends Neurosci 29 349 358
28. BoeckersTMKreutzMRWinterCZuschratterWSmallaKH 1999 Proline-rich synapse-associated protein-1/cortactin binding protein 1 (ProSAP1/CortBP1) is a PDZ-domain protein highly enriched in the postsynaptic density. J Neurosci 19 6506 6518
29. ShengMKimE 2000 The Shank family of scaffold proteins. J Cell Sci 113 Pt 11 1851 1856
30. McWilliamsRRGideyEFouassierLWeedSADoctorRB 2004 Characterization of an ankyrin repeat-containing Shank2 isoform (Shank2E) in liver epithelial cells. Biochem J 380 181 191
31. BoeckersTMWinterCSmallaKHKreutzMRBockmannJ 1999 Proline-rich synapse-associated proteins ProSAP1 and ProSAP2 interact with synaptic proteins of the SAPAP/GKAP family. Biochem Biophys Res Commun 264 247 252
32. LimSNaisbittSYoonJHwangJISuhPG 1999 Characterization of the Shank family of synaptic proteins. Multiple genes, alternative splicing, and differential expression in brain and development. J Biol Chem 274 29510 29518
33. DurandCMKappelerCBetancurCDelormeRQuachH 2006 Expression and genetic variability of PCDH11Y, a gene specific to Homo sapiens and candidate for susceptibility to psychiatric disorders. Am J Med Genet B Neuropsychiatr Genet 141 67 70
34. GutierrezRCFlynnRHungJKerteszACSullivanA 2009 Activity-driven mobilization of post-synaptic proteins. Eur J Neurosci 30 2042 2052
35. WischmeijerAMaginiPGiordaRGnoliMCicconeR 2010 Olfactory Receptor-Related Duplicons Mediate a Microdeletion at 11q13.2q13.4 Associated with a Syndromic Phenotype. Mol Syndromol 1 176 184
36. BrandstatterJHDickOBoeckersTM 2004 The postsynaptic scaffold proteins ProSAP1/Shank2 and Homer1 are associated with glutamate receptor complexes at rat retinal synapses. J Comp Neurol 475 551 563
37. RosmondRBjorntorpP 1998 Psychiatric ill-health of women and its relationship to obesity and body fat distribution. Obes Res 6 338 345
38. CloningerCRSvrakicDMPrzybeckTR 1993 A psychobiological model of temperament and character. Arch Gen Psychiatry 50 975 990
39. SchallingDAsbergMEdmanGOrelandL 1987 Markers for vulnerability to psychopathology: temperament traits associated with platelet MAO activity. Acta Psychiatr Scand 76 172 182
40. MelkeJWestbergLNilssonSLandenMSoderstromH 2003 A polymorphism in the serotonin receptor 3A (HTR3A) gene and its association with harm avoidance in women. Arch Gen Psychiatry 60 1017 1023
41. AdzhubeiIASchmidtSPeshkinLRamenskyVEGerasimovaA 2010 A method and server for predicting damaging missense mutations. Nat Methods 7 248 249
42. MarshallCRNoorAVincentJBLionelACFeukL 2008 Structural variation of chromosomes in autism spectrum disorder. Am J Hum Genet 82 477 488
43. MillerDTShenYWeissLAKornJAnselmI 2009 Microdeletion/duplication at 15q13.2q13.3 among individuals with features of autism and other neuropsychiatric disorders. J Med Genet 46 242 248
44. DepienneCMoreno-De-LucaDHeronDBouteillerDGennetierA 2009 Screening for genomic rearrangements and methylation abnormalities of the 15q11–q13 region in autism spectrum disorders. Biol Psychiatry 66 349 359
45. van der ZwaagBStaalWGHochstenbachRPootMSpierenburgHA 2010 A co-segregating microduplication of chromosome 15q11.2 pinpoints two risk genes for autism spectrum disorder. Am J Med Genet B Neuropsychiatr Genet 153B 960 966
46. ShenYDiesKAHolmIABridgemohanCSobeihMM 2010 Clinical genetic testing for patients with autism spectrum disorders. Pediatrics 125 e727 735
47. SharpAJMeffordHCLiKBakerCSkinnerC 2008 A recurrent 15q13.3 microdeletion syndrome associated with mental retardation and seizures. Nat Genet 40 322 328
48. Masurel-PauletAAndrieuxJCallierPCuissetJMLe CaignecC 2010 Delineation of 15q13.3 microdeletions. Clin Genet 78 149 161
49. DoornbosMSikkema-RaddatzBRuijvenkampCADijkhuizenTBijlsmaEK 2009 Nine patients with a microdeletion 15q11.2 between breakpoints 1 and 2 of the Prader-Willi critical region, possibly associated with behavioural disturbances. Eur J Med Genet 52 108 115
50. HelbigIMeffordHCSharpAJGuipponiMFicheraM 2009 15q13.3 microdeletions increase risk of idiopathic generalized epilepsy. Nat Genet 41 160 162
51. SzafranskiPSchaafCPPersonREGibsonIBXiaZ 2010 Structures and molecular mechanisms for common 15q13.3 microduplications involving CHRNA7: benign or pathological? Hum Mutat 31 840 850
52. Ben-ShacharSLanpherBGermanJRQasaymehMPotockiL 2009 Microdeletion 15q13.3: a locus with incomplete penetrance for autism, mental retardation, and psychiatric disorders. J Med Genet 46 382 388
53. StefanssonHRujescuDCichonSPietilainenOPIngasonA 2008 Large recurrent microdeletions associated with schizophrenia. Nature 455 232 236
54. International Schizophrenia Consortium 2008 Rare chromosomal deletions and duplications increase risk of schizophrenia. Nature 455 237 241
55. TamGWvan de LagemaatLNRedonRStrathdeeKECroningMD 2010 Confirmed rare copy number variants implicate novel genes in schizophrenia. Biochem Soc Trans 38 445 451
56. MurthySKNygrenAOEl ShakankiryHMSchoutenJPAl KhayatAI 2007 Detection of a novel familial deletion of four genes between BP1 and BP2 of the Prader-Willi/Angelman syndrome critical region by oligo-array CGH in a child with neurological disorder and speech impairment. Cytogenet Genome Res 116 135 140
57. ShinawiMSchaafCPBhattSSXiaZPatelA 2009 A small recurrent deletion within 15q13.3 is associated with a range of neurodevelopmental phenotypes. Nat Genet 41 1269 1271
58. van BonBWMeffordHCMentenBKoolenDASharpAJ 2009 Further delineation of the 15q13 microdeletion and duplication syndromes: a clinical spectrum varying from non-pathogenic to a severe outcome. J Med Genet 46 511 523
59. PagnamentaATWingKAkhaESKnightSJBolteS 2009 A 15q13.3 microdeletion segregating with autism. Eur J Hum Genet 17 687 692
60. KirovGGrozevaDNortonNIvanovDMantripragadaKK 2009 Support for the involvement of large copy number variants in the pathogenesis of schizophrenia. Hum Mol Genet 18 1497 1503
61. de KovelCGTrucksHHelbigIMeffordHCBakerC 2010 Recurrent microdeletions at 15q11.2 and 16p13.11 predispose to idiopathic generalized epilepsies. Brain 133 23 32
62. CottrellCEBirNVargaEAlvarezCEBouyainS 2010 Contactin 4 as an autism susceptibility locus. Autism Res
63. RosenfeldJABallifBCTorchiaBSSahooTRavnanJB 2010 Copy number variations associated with autism spectrum disorders contribute to a spectrum of neurodevelopmental disorders. Genet Med 12 694 702
64. ChristianSLBruneCWSudiJKumarRALiuS 2008 Novel submicroscopic chromosomal abnormalities detected in autism spectrum disorder. Biol Psychiatry 63 1111 1117
65. VrijenhoekTBuizer-VoskampJEvan der SteltIStrengmanESabattiC 2008 Recurrent CNVs disrupt three candidate genes in schizophrenia patients. Am J Hum Genet 83 504 510
66. YamakawaHOyamaSMitsuhashiHSasagawaNUchinoS 2007 Neuroligins 3 and 4X interact with syntrophin-gamma2, and the interactions are affected by autism-related mutations. Biochem Biophys Res Commun 355 41 46
67. AlessiABraggADPercivalJMYooJAlbrechtDE 2006 gamma-Syntrophin scaffolding is spatially and functionally distinct from that of the alpha/beta syntrophins. Exp Cell Res 312 3084 3095
68. VierbuchenTOstermeierAPangZPKokubuYSudhofTC 2010 Direct conversion of fibroblasts to functional neurons by defined factors. Nature 463 1035 1041
69. DurandCMPerroyJLollFPerraisDFagniL 2011 SHANK3 mutations identified in autism lead to modification of dendritic spine morphology via an actin-dependent mechanism. Mol Psychiatry
70. BerkelSTangWTrevinoMVogtMObenhausHA 2011 Inherited and de novo SHANK2 variants associated with autism spectrum disorder impair neuronal morphogenesis and physiology. Hum Mol Genet
71. DurbinRMAbecasisGRAltshulerDLAutonABrooksLD 2010 A map of human genome variation from population-scale sequencing. Nature 467 1061 1073
72. The international schizophrenia consortium 2008 Rare chromosomal deletions and duplications increase risk of schizophrenia. Nature 455 237 241
73. YasuiDHScolesHAHorikeSIMeguro-HorikeMDunawayKW 2011 15q11.2–13.3 chromatin analysis reveals epigenetic regulation of CHRNA7 with deficiencies in Rett and autism brain. Hum Mol Genet
74. Meguro-HorikeMYasuiDHPowellWSchroederDIOshimuraM 2011 Neuron-specific impairment of inter-chromosomal pairing and transcription in a novel model of human 15q-duplication syndrome. Hum Mol Genet 20 3798 3810
75. HogartALeungKNWangNJWuDJDriscollJ 2009 Chromosome 15q11–13 duplication syndrome brain reveals epigenetic alterations in gene expression not predicted from copy number. J Med Genet 46 86 93
76. Triana-BaltzerGBLiuZGounkoNVBergDK 2008 Multiple cell adhesion molecules shaping a complex nicotinic synapse on neurons. Mol Cell Neurosci 39 74 82
77. ChengSBAmiciSARenXQMcKaySBTreuilMW 2009 Presynaptic targeting of alpha4beta 2 nicotinic acetylcholine receptors is regulated by neurexin-1beta. J Biol Chem 284 23251 23259
78. NeffRA3rdGomez-VarelaDFernandesCCBergDK 2009 Postsynaptic scaffolds for nicotinic receptors on neurons. Acta Pharmacol Sin 30 694 701
79. SchenckABardoniBLangmannCHardenNMandelJL 2003 CYFIP/Sra-1 controls neuronal connectivity in Drosophila and links the Rac1 GTPase pathway to the fragile X protein. Neuron 38 887 898
80. KelleherRJ3rdBearMF 2008 The autistic neuron: troubled translation? Cell 135 401 406
81. BoeckersTMBockmannJKreutzMRGundelfingerED 2002 ProSAP/Shank proteins - a family of higher order organizing molecules of the postsynaptic density with an emerging role in human neurological disease. J Neurochem 81 903 910
82. SugiyamaYKawabataISobueKOkabeS 2005 Determination of absolute protein numbers in single synapses by a GFP-based calibration technique. Nat Methods 2 677 684
83. NagaiRHashimotoRTanakaYTaguchiOSatoM 2010 Syntrophin-2 is required for eye development in Drosophila. Exp Cell Res 316 272 285
84. DolenGOsterweilERaoBSSmithGBAuerbachBD 2007 Correction of fragile X syndrome in mice. Neuron 56 955 962
85. VissersLEde LigtJGilissenCJanssenISteehouwerM 2010 A de novo paradigm for mental retardation. Nat Genet 42 1109 1112
86. ColellaSYauCTaylorJMMirzaGButlerH 2007 QuantiSNP: an Objective Bayes Hidden-Markov Model to detect and accurately map copy number variation using SNP genotyping data. Nucleic Acids Res 35 2013 2025
87. WangKLiMHadleyDLiuRGlessnerJ 2007 PennCNV: an integrated hidden Markov model designed for high-resolution copy number variation detection in whole-genome SNP genotyping data. Genome Res 17 1665 1674
88. BoeckersTMLiedtkeTSpilkerCDresbachTBockmannJ 2005 C-terminal synaptic targeting elements for postsynaptic density proteins ProSAP1/Shank2 and ProSAP2/Shank3. J Neurochem 92 519 524
Štítky
Genetika Reprodukčná medicínaČlánok vyšiel v časopise
PLOS Genetics
2012 Číslo 2
- Je „freeze-all“ pro všechny? Odborníci na fertilitu diskutovali na virtuálním summitu
- Gynekologové a odborníci na reprodukční medicínu se sejdou na prvním virtuálním summitu
Najčítanejšie v tomto čísle
- Gene Expression and Stress Response Mediated by the Epigenetic Regulation of a Transposable Element Small RNA
- Contrasting Properties of Gene-Specific Regulatory, Coding, and Copy Number Mutations in : Frequency, Effects, and Dominance
- Homeobox Genes Critically Regulate Embryo Implantation by Controlling Paracrine Signaling between Uterine Stroma and Epithelium
- Nondisjunction of a Single Chromosome Leads to Breakage and Activation of DNA Damage Checkpoint in G2